ARTES enters into a partnership with Henkel in a 3‑year research program

ARTES Biotech­nol­o­gy GmbH today announces the col­lab­o­ra­tion with Henkel in a joint three years research pro­gram that is grant­ed by the Ger­man nation­al BMBF (Ger­man Min­is­tery of Edu­ca­tion and Research) with­in the CLIB2021 clus­ter (Wet­tbe­werb Indus­trielle Biotech­nolo­gie 2021). The coop­er­a­tion aims at the devel­op­ment and man­u­fac­tur­ing of pep­tides with adhe­sive properties.

ARTES will apply its pro­pri­etary tech­nol­o­gy plat­forms – the yeast expres­sion tech­nolo­gies Hansenu­la and Arx­u­la and the Chap­er­one tech­nol­o­gy for improved secre­tion. The gen­er­a­tion of pro­duc­tion cell lines, ana­lyt­i­cal assay devel­op­ment, and lab-scale fermentation/down stream process devel­op­ment are ARTES´ respon­si­bil­i­ties in this coop­er­a­tion. Inno­v­a­tive strate­gies for the pro­duc­tion of dif­fi­cult-to-express adhe­sive pep­tides shall be devel­oped, result­ing in next gen­er­a­tion tools for ARTES´ con­tract R&D.